Bodal Chemicals Ltd

On 21-Nov, Bodal Chemicals Ltd witnessed a notable decline in its share price, closing at ₹54.51, down by ₹1.25 or 2.24%. This drop reflects a continuation of the stock's underperformance relative to broader market indices and sector peers, compounded by weakening investor participation and technical indicators signalling bearish momentum.

As of 14-Nov, Bodal Chemicals Ltd is facing a decline in stock price, currently at 57.60, down 1.4%, and has underperformed its sector. The stock has dropped 3.82% over the last three days and is trading below all moving averages, with a year-to-date decline of 14.76% compared to the Sensex's increase.

As of November 13, 2025, Bodal Chemicals is considered an attractive investment due to its undervalued status, with a PE ratio of 20.27, an EV to EBITDA of 9.69, and a Price to Book Value of 0.66, making it significantly cheaper than peers like Sudarshan Chemicals and Kiri Industries, despite a year-to-date return of -13.54%.

Bodal Chemicals reported record revenue of ₹480.45 crores for the quarter ending September 2025, but faced significant operational challenges with a net profit decline of 37.15% and low operating margins, raising concerns about its financial sustainability. The company's stock has also underperformed, reflecting investor skepticism.

Bodal Chemicals has shown fluctuating historical performance, with net sales increasing to 1,744.94 Cr in March 2025 from 1,394.62 Cr in March 2024, but still lower than 2,050.62 Cr in March 2022. While profits improved, cash flow declined, indicating mixed results overall.

As of 08-Oct, Bodal Chemicals Ltd's stock price is declining at 61.01, down 1.29%, and has underperformed its sector and the benchmark Sensex. Despite positive quarterly results, the stock has a significant negative return of 24.68% over the past year, reflecting weak long-term fundamentals and a lack of investor confidence.

As of October 6, 2025, Bodal Chemicals has shifted to a bearish technical stance, supported by bearish MACD, Bollinger Bands, and moving averages, despite a conflicting bullish RSI on the weekly chart.

As of October 1, 2025, Bodal Chemicals is considered very attractive and undervalued with a PE ratio of 25.93, significantly lower than its peers, suggesting it may be a compelling investment opportunity despite a recent 1Y return of -26.25%.

As of October 1, 2025, Bodal Chemicals is considered very attractive and undervalued, with a PE ratio of 25.93, an EV to EBITDA of 9.61, and a PEG ratio of 0.03, making it a compelling investment opportunity despite a recent stock decline of 26.25% compared to the Sensex's drop of 3.90%.

As of September 25, 2025, Bodal Chemicals shows a mildly bearish trend, supported by bearish weekly MACD and KST indicators, Bollinger Bands, and underperformance against the Sensex, despite some mildly bullish signals from daily moving averages.

As of 24-Sep, Bodal Chemicals Ltd is priced at 64.35, down 1.36% and has underperformed the market with a one-week return of -4.21%. Despite positive operating profit growth, weak long-term fundamentals and decreased investor interest suggest a bearish outlook for the stock.

As of September 23, 2025, Bodal Chemicals shows a neutral trend with mixed signals: weekly indicators are bearish, monthly indicators are mildly bullish, and daily moving averages suggest short-term strength, while the stock has underperformed against the Sensex over the past 1 to 3 years.